Comparison Of The Efficacy And Safety Of Secukinumab, Ustekinumab And Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis: A Systematic Review. Journal of Pharmaceutical Negative Results [Internet]. 2023 Jan. 1 [cited 2026 Jun. 9];:485-9. Available from: https://www.pnrjournal.com/index.php/home/article/view/7231